AstraZeneca gets breakthrough status for blood cancer drug

loading...


AstraZeneca gets breakthrough status for blood cancer drug
LONDON (Reuters) – AstraZeneca said on Tuesday that U.S. regulators had awarded its blood cancer drug acalabrutinib “breakthrough” status for the treatment of patients with mantle cell lymphoma, a rare type of blood cancer.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...